Medical Care Technologies Statistics
Total Valuation
MDCE has a market cap or net worth of 650,033. The enterprise value is 169,483.
| Market Cap | 650,033 |
| Enterprise Value | 169,483 |
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDCE has 3.25 billion shares outstanding. The number of shares has increased by 1.27% in one year.
| Current Share Class | 3.25B |
| Shares Outstanding | 3.25B |
| Shares Change (YoY) | +1.27% |
| Shares Change (QoQ) | +1.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 2.82.
| PE Ratio | 2.82 |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.65 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.73 |
| EV / Sales | 0.16 |
| EV / EBITDA | n/a |
| EV / EBIT | 0.71 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 70.69, with a Debt / Equity ratio of 0.01.
| Current Ratio | 70.69 |
| Quick Ratio | 18.39 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 32.49 |
Financial Efficiency
Return on equity (ROE) is 14.23% and return on invested capital (ROIC) is 8.96%.
| Return on Equity (ROE) | 14.23% |
| Return on Assets (ROA) | 8.88% |
| Return on Invested Capital (ROIC) | 8.96% |
| Return on Capital Employed (ROCE) | 12.80% |
| Weighted Average Cost of Capital (WACC) | 4.04% |
| Revenue Per Employee | 1.07M |
| Profits Per Employee | 230,768 |
| Employee Count | 1 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 0.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is -0.19, so MDCE's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 33.13 |
| Average Volume (20 Days) | 19,591,292 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, MDCE had revenue of 1.07 million and earned 230,768 in profits. Earnings per share was 0.00.
| Revenue | 1.07M |
| Gross Profit | 576,121 |
| Operating Income | 238,065 |
| Pretax Income | 230,768 |
| Net Income | 230,768 |
| EBITDA | n/a |
| EBIT | 238,065 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 490,546 in cash and 10,000 in debt, giving a net cash position of 480,546 or 0.00 per share.
| Cash & Cash Equivalents | 490,546 |
| Total Debt | 10,000 |
| Net Cash | 480,546 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.86M |
| Book Value Per Share | 0.00 |
| Working Capital | 1.86M |
Cash Flow
| Operating Cash Flow | 97,796 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 53.75%, with operating and profit margins of 22.21% and 21.53%.
| Gross Margin | 53.75% |
| Operating Margin | 22.21% |
| Pretax Margin | 21.53% |
| Profit Margin | 21.53% |
| EBITDA Margin | n/a |
| EBIT Margin | 22.21% |
| FCF Margin | n/a |
Dividends & Yields
MDCE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.27% |
| Shareholder Yield | -1.27% |
| Earnings Yield | 35.50% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 25, 2014. It was a reverse split with a ratio of 0.001.
| Last Split Date | Aug 25, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.001 |
Scores
MDCE has an Altman Z-Score of 19.66 and a Piotroski F-Score of 5.
| Altman Z-Score | 19.66 |
| Piotroski F-Score | 5 |